$23.01
0.00%
Nasdaq, Mon, Dec 30 2024
ISIN
US41358P1066
Symbol
HARP
Sector
Industry

Harpoon Therapeutics, Inc. Target price 2024 - Analyst rating & recommendation

Harpoon Therapeutics, Inc. Classifications & Recommendation:

Hold
100%

Harpoon Therapeutics, Inc. Price Target

Target Price $24.37
Price $23.01
Potential
Number of Estimates 1
1 Analyst has issued a Harpoon Therapeutics, Inc. price target 2025. The average Harpoon Therapeutics, Inc. target price is $24.37. This is higher than the current stock price.
A rating was issued by 2 analysts: 0 Analysts recommend Harpoon Therapeutics, Inc. to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Harpoon Therapeutics, Inc. stock has an average upside potential 2025 of . Most analysts recommend the Harpoon Therapeutics, Inc. stock at Hold.

Sales and Margin forecast 2023, 2024 to 2026

Create a premium account to unlock analyst estimates. Learn more

Dec '22 2023
Estimates
Revenue Million $ 31.92 42.11
34.97% 31.91%
Net Margin -262.93% -16.50%
58.17% 93.72%

3 Analysts have issued a sales forecast Harpoon Therapeutics, Inc. 2023 . The average Harpoon Therapeutics, Inc. sales estimate is

$42.1m
Unlock
. This is
12.77% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$46.0m 23.19%
Unlock
, the lowest is
$37.0m 0.86%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2022 $31.9m 34.97%
2023
$42.1m 31.91%
Unlock
2024
$50.0m 18.75%
Unlock
2025
$50.0m 0.00%
Unlock
2026
$75.0m 50.00%
Unlock

The average Harpoon Therapeutics, Inc. net profit estimate is

$-7.0m
Unlock
. This is
80.59% higher
Unlock
than the net profit for the last 12 months(TTM).

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2022 $-83.9m 43.54%
2023
$-7.0m 91.72%
Unlock
2024
$-41.1m 491.37%
Unlock

Net Margin

2022 -262.93% 58.17%
2023
-16.50% 93.72%
Unlock
2024
-82.20% 398.18%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2023, 2024 to 2026

Create a premium account to unlock analyst estimates. Learn more

Dec '22 2023
Estimates
Earnings Per Share $ -20.42 -1.69
43.54% 91.72%
P/E negative
EV/Sales 1.84

The average Harpoon Therapeutics, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-1.69
Unlock
. This is
80.60% higher
Unlock
than earnings per share in the financial year 2022.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2022 $-20.42 43.54%
2023
$-1.69 91.72%
Unlock
2024
$-10.00 491.72%
Unlock

P/E ratio

Current -2.64 91.30%
2023
-13.62 415.91%
Unlock
2024
-2.30 83.11%
Unlock

Based on analysts' sales estimates for 2023, the Harpoon Therapeutics, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.07 58.43%
2023
1.84 11.16%
Unlock
2024
1.55 15.79%
Unlock
2025
1.55 0.00%
Unlock
2026
1.03 33.33%
Unlock

P/S ratio

Current 2.53 53.47%
2023
2.25 11.32%
Unlock
2024
1.89 15.79%
Unlock
2025
1.89 0.00%
Unlock
2026
1.26 33.34%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today